The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancerYue Pan, Fang Wu, Chao Deng et al.|Biomarker Research|2022Cited by 57
Tertiary Lymphoid Structures: A Potential Biomarker for Anti-Cancer TherapyJian Zou, Fang Wu, Yingzhe Zhang et al.|Cancers|2022Cited by 19
Immunometabolism: a new dimension in immunotherapy resistanceChaoyue Xiao, Fang Wu, Chunhong Hu et al.|Frontiers of Medicine|2023Cited by 15